FDA Approves First Biosimilar for Cancer Treatment Highlights SPT Week in Review


Top news of the week from Specialty Pharmacy Times.

5. Curing AIDS, The Time Is Now: Gene-Editing Technology May Eliminate HIV

Company harnesses CRISPR-based gene editing technology as it enters human clinical trials to treat HIV. Read more…

4. Herpes Virus-Immunotherapy Combo Improves Melanoma Treatment

Patients with drug-resistant melanoma treated with a herpes virus-pembrolizumab drug combination showed a complete or partial response. Read more…

3. Microfluidic Device Tracks Long-term Evolution of Cancer Cells to Gain Insight into Metastasis

Device may reveal how to stop cancer cells from spreading. Read more…

2. Herceptin Biosimilar Demonstrates Equivalence in Comparative Phase 3 Study

Investigational trastuzumab biosimilar shows promise as potential lower cost treatment option to Herceptin for breast cancer and gastric cancer. Read more…

1. FDA Approves First Biosimilar for Treatment of Cancer

Bevacizumab-awwb, a biosimilar to Avastin, approved to treat several cancer types. Read more…

Related Videos
Atopic dermatitis on a patient's hand -- Image credit: Ольга Тернавская | stock.adobe.com
biosimilar word or concept represented by wooden letter tiles on a wooden table with glasses and a book | Image Credit: lexiconimages - stock.adobe.com
Image credit: alicja neumiler | stock.adobe.com
Laboratory test tubes and solution with stethoscope background | Image Credit: Shutter2U - stock.adobe.com
Pharmacist preparing high-risk chemotherapy
© 2024 MJH Life Sciences

All rights reserved.